CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Epicore Biosystems and MECFA Announce Collaboration to Expand Access to Wearable Sweat Chloride Testing for Cystic Fibrosis

PartnershipWearable Sweat Chloride TestingPositive
AI Analysis

Summary

Epicore Biosystems and MECFA announced a collaboration to expand access to wearable sweat chloride testing for cystic fibrosis monitoring in the Middle East and other underserved regions.

Importance:5/10
Sentiment:
0.60
partnershipwearable technologycystic fibrosisdiagnosticexpansionMiddle East
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on October 6, 2026 1:30 PM

Read Original